Jay S. Loeffler

Active 1985–2022

Also published as
Jay S Loeffler
162
Papers
37,221
Citations
109
h-index
162
i10-index

Citations

Citations per year for Jay S. Loeffler1959: 1 citations1986: 3 citations1989: 3 citations1990: 6 citations1991: 26 citations1992: 25 citations1993: 34 citations1994: 58 citations1995: 61 citations1996: 60 citations1997: 73 citations1998: 107 citations1999: 96 citations2000: 126 citations2001: 101 citations2002: 126 citations2003: 184 citations2004: 180 citations2005: 225 citations2006: 214 citations2007: 254 citations2008: 292 citations2009: 362 citations2010: 298 citations2011: 338 citations2012: 331 citations2013: 319 citations2014: 325 citations2015: 274 citations2016: 248 citations2017: 220 citations2018: 222 citations2019: 786 citations2020: 856 citations2021: 790 citations2022: 570 citations2023: 433 citations2024: 700 citations2025: 291 citations2026: 14 citations1960–1985: no citations, so these years are not shown1987–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,885 citing papers, 32.7% of this breakdownChina: 1,041 citing papers, 8.8% of this breakdownGermany: 895 citing papers, 7.5% of this breakdownItaly: 664 citing papers, 5.6% of this breakdownUnited Kingdom: 620 citing papers, 5.2% of this breakdownFrance: 450 citing papers, 3.8% of this breakdownCanada: 417 citing papers, 3.5% of this breakdownNetherlands: 345 citing papers, 2.9% of this breakdownJapan: 334 citing papers, 2.8% of this breakdownSwitzerland: 326 citing papers, 2.8% of this breakdownAustralia: 238 citing papers, 2% of this breakdownSpain: 221 citing papers, 1.9% of this breakdown
0%32.7%Other 20.5%

Fields

  • Medicine71.2%
  • Biochemistry, Genetics and Molecular Biology17.8%
  • Physics and Astronomy2.4%
  • Engineering2.1%
  • Neuroscience1.7%
  • Immunology and Microbiology1.4%
  • Other3.4%

Topics

  • Glioma Diagnosis and Treatment11.2%
  • Brain Metastases and Treatment6.9%
  • Meningioma and schwannoma management3.9%
  • Radiation Therapy and Dosimetry3.7%
  • Advanced Radiotherapy Techniques3.6%
  • Angiogenesis and VEGF in Cancer2.5%
  • Other68.2%

Coauthors

All papers

Open in search
  1. Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lan Nguyễn, Toni Delorey, Devan Phillips, Jaimie L. Barth, Marina Kem, Clifton Rodrigues, Debora Ciprani, Jorge Roldán, Piotr Zelga, Vjola Jorgji, Jonathan Chen, Zackery A. Ely, Daniel Zhao, Kit Fuhrman, Robin Fropf, Joseph Beechem, Jay S. Loeffler, David P. Ryan, Colin D. Weekes, Cristina R. Ferrone, Motaz Qadan, Martin J. Aryee, Rakesh K. Jain, Donna Neuberg, Jennifer Y. Wo, Theodore S. Hong, Ramnik J. Xavier, Andrew J. Aguirre, Orit Rozenblatt–Rosen, Mari Mino–Kenudson, Carlos Fernández‐del Castillo, Andrew S. Liss, David T. Ting, Tyler Jacks, Aviv Regev - Nature Genetics 2022 cited by 413

  2. Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephanie E. Weiss, Patrick Y. Wen, Nicole E. Willmarth, Mary Anne Bergman, Susan Darlow - Journal of the National Comprehensive Cancer Network 2020 cited by 564

  3. Relative biological effectiveness (RBE) values for proton beam therapy

    Authors: , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2002 cited by 1,341

  4. Therapeutic avenues for cancer neuroscience: translational frontiers and clinical opportunities

    Authors: , , , , , , , , , , , , , , , , - The Lancet Oncology 2022 cited by 127

  5. Angiogenesis in brain tumours

    Authors: , , , , , - Nature reviews. Neuroscience 2007 cited by 1,390

  6. Safety of combining radiotherapy with immune-checkpoint inhibition

    Authors: , , , , - Nature Reviews Clinical Oncology 2018 cited by 293

  7. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05

    Authors: , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2000 cited by 1,600

  8. AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients

    Authors: , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2007 cited by 1,765

  9. The biology of brain metastases—translation to new therapies

    Authors: , , , , , - Nature Reviews Clinical Oncology 2011 cited by 575

  10. Physics and biomedical challenges of cancer therapy with accelerated heavy ions

    Authors: , , - Nature Reviews Physics 2021 cited by 166

  11. Charged-particle therapy in cancer: clinical uses and future perspectives

    Authors: , , - Nature Reviews Clinical Oncology 2017 cited by 473

  12. Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement

    Authors: , , , , , , , , , , - Pituitary 2017 cited by 315

  13. Assessing the interactions between radiotherapy and antitumour immunity

    Authors: , , , , - Nature Reviews Clinical Oncology 2019 cited by 248

  14. Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

    Authors: , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2014 cited by 250

  15. Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2022 cited by 112

  16. Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation

    Authors: , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 342

  17. NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christina Tsien, Stephanie E. Weiss, Patrick Y. Wen, Nicole E. Willmarth, Mary Anne Bergman, Anita M. Engh - Journal of the National Comprehensive Cancer Network 2017 cited by 231

  18. Charged particles in radiation oncology

    Authors: , - Nature Reviews Clinical Oncology 2009 cited by 709

  19. Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2010 cited by 516

  20. Lessons From Anti–Vascular Endothelial Growth Factor and Anti–Vascular Endothelial Growth Factor Receptor Trials in Patients With Glioblastoma

    Authors: , , , , , , , - Journal of Clinical Oncology 2015 cited by 178

  21. Proton therapy for low‐grade gliomas: Results from a prospective trial

    Authors: , , , , , , , , , , , , , , - Cancer 2015 cited by 151

  22. Treatment-induced brain tissue necrosis: a clinical challenge in neuro-oncology

    Authors: , , , , , , - Neuro-Oncology 2019 cited by 82

  23. Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade glioma

    Authors: , , , , , , , , , , , , , - Radiotherapy and Oncology 2019 cited by 89

  24. Biomarkers of response and resistance to antiangiogenic therapy

    Authors: , , , , , , , - Nature Reviews Clinical Oncology 2009 cited by 574